Application 050779
- Type
- NDA
- Sponsor
- B BRAUN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | INJECTABLE;INJECTION | EQ 500MG BASE/VIAL | No | No |
| 002 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | INJECTABLE;INJECTION | EQ 1GM BASE/VIAL | Yes | Yes |
| 003 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | INJECTABLE;INJECTION | EQ 2GM BASE/VIAL | Yes | No |
| 004 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | INJECTABLE;INJECTION | EQ 3GM BASE/VIAL | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050779-001 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | ||
| N050779-002 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | |
| N050779-003 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | |
| N050779-004 | CEFAZOLIN AND DEXTROSE | CEFAZOLIN SODIUM | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N050779-004 | CEFAZOLIN AND DEXTROSE | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N050779-004 | CEFAZOLIN AND DEXTROSE | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050779-004 | CEFAZOLIN AND DEXTROSE | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050779-004 | CEFAZOLIN AND DEXTROSE | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050779-004 | CEFAZOLIN AND DEXTROSE | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050779-004 | CEFAZOLIN AND DEXTROSE | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050779-004 | CEFAZOLIN AND DEXTROSE | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050779-004 | CEFAZOLIN AND DEXTROSE | EQ 3GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2024-08-26 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050779-003 | CEFAZOLIN AND DEXTROSE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | RLD | 2012-01-13 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050779-001 | CEFAZOLIN AND DEXTROSE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | 2000-07-27 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050779-002 | CEFAZOLIN AND DEXTROSE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | RLD, RS | 2000-07-27 | d8e5a09893c0… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-12-20 04:57 UTC | 2023-12 | N050779-001 | NPP | 2023-11-23 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | N050779-002 | NPP | 2023-11-23 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | N050779-003 | NPP | 2023-11-23 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N050779-001 | NPP | 2023-11-23 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N050779-002 | NPP | 2023-11-23 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N050779-003 | NPP | 2023-11-23 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N050779-001 | NPP | 2023-11-23 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N050779-002 | NPP | 2023-11-23 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N050779-003 | NPP | 2023-11-23 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N050779-001 | NPP | 2023-11-23 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N050779-002 | NPP | 2023-11-23 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N050779-003 | NPP | 2023-11-23 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N050779-001 | NPP | 2023-11-23 | 3f0d92c62455… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N050779-002 | NPP | 2023-11-23 | 3f0d92c62455… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N050779-003 | NPP | 2023-11-23 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | N050779-001 | NPP | 2023-11-23 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | N050779-002 | NPP | 2023-11-23 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | N050779-003 | NPP | 2023-11-23 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N050779-001 | NPP | 2023-11-23 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | N050779-002 | NPP | 2023-11-23 | 3bdfa0b2c4d7… |
| 2023-01-26 05:58 UTC | 2023-01 | N050779-003 | NPP | 2023-11-23 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N050779-001 | NPP | 2023-11-23 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N050779-002 | NPP | 2023-11-23 | 3a93d1ddd44b… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N050779-003 | NPP | 2023-11-23 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N050779-001 | NPP | 2023-11-23 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N050779-002 | NPP | 2023-11-23 | f41ea6bd6efb… |
| 2022-10-28 04:53 UTC | 2022-10 | N050779-003 | NPP | 2023-11-23 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N050779-001 | NPP | 2023-11-23 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N050779-002 | NPP | 2023-11-23 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | N050779-003 | NPP | 2023-11-23 | e64feba35796… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefazolin Sodium | CEFAZOLIN SODIUM | B. Braun Medical Inc. | 17f8f038-c204-4dab-80d7-6f7ac41ddbec | 2025-03-10 | Warnings, Adverse reactions | 050779 NDA050779 0264-3103 0264-3105 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0264-3103 | Cefazolin Sodium | Cefazolin Sodium | B. Braun Medical Inc. | NDA | Current |
| 0264-3103 | Cefazolin Sodium | Cefazolin Sodium | B. Braun Medical Inc. | NDA | Current |
| 0264-3103 | Cefazolin Sodium | Cefazolin Sodium | B. Braun Medical Inc. | NDA | Current |
| 0264-3105 | Cefazolin Sodium | Cefazolin Sodium | B. Braun Medical Inc. | NDA | Current |
| 0264-3105 | Cefazolin Sodium | Cefazolin Sodium | B. Braun Medical Inc. | NDA | Current |
| 0264-3105 | Cefazolin Sodium | Cefazolin Sodium | B. Braun Medical Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 80901 | SUPPL | 2025-02-04 |
| 79510 | SUPPL | 2024-09-02 |
| 79485 | SUPPL | 2024-08-27 |
| 68975 | SUPPL | 2021-10-13 |
| 68962 | SUPPL | 2021-10-12 |
| 65344 | SUPPL | 2020-11-25 |
| 65328 | SUPPL | 2020-11-25 |
| 64234 | SUPPL | 2020-08-07 |
| 39321 | SUPPL | 2015-10-15 |
| 30525 | SUPPL | 2015-10-13 |
| 30524 | SUPPL | 2014-09-23 |
| 30523 | SUPPL | 2012-04-25 |
| 39320 | SUPPL | 2012-04-23 |
| 18231 | SUPPL | 2012-01-26 |
| 30522 | SUPPL | 2012-01-18 |
| 8269 | SUPPL | 2008-11-07 |
| 42732 | SUPPL | 2007-09-24 |
| 39319 | SUPPL | 2007-09-11 |
| 8270 | SUPPL | 2007-09-11 |
| 30521 | SUPPL | 2005-05-17 |
| 39318 | SUPPL | 2004-07-01 |
| 8268 | SUPPL | 2004-07-01 |
| 22235 | ORIG | 2000-08-04 |
| 18230 | ORIG | 2000-08-04 |
| 8267 | ORIG | 2000-08-04 |